Prime Medicine (NASDAQ: PRME) shares jumped more than 12% in after-hours trading Thursday after the U.S. Food and Drug Administration
1 day ago
Pfizer Inc. (NYSE: PFE) and Eli Lilly and Company (NYSE: LLY) head into the new trading week with fresh U.S.
6 days ago
By late Wednesday morning, Moderna (NASDAQ: MRNA) stock was up about 133%, while Merck (NYSE: MRK) had risen about 11%,
1 month ago
Replimune Group (NASDAQ: REPL) stock soared 107.02% during Friday’s regular trading session after a U.S. Food and Drug Administration (FDA)
2 months ago
Gossamer Bio stock (NASDAQ: GOSS) rallied sharply on Monday after the clinical-stage biotech company said the U.S. Food and Drug
Capricor Therapeutics stock (NASDAQ: CAPR) plunged about 65% on July 27 after FDA briefing documents raised fresh doubts about whether
Shares of Hims & Hers Health (NYSE: HIMS) extended their momentum Thursday, climbing about 11% in premarket trading after a
5 months ago
Cocrystal Pharma (NASDAQ: COCP) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its
6 months ago
Cyclerion Therapeutics’ merger with Korsana Biosciences has closed, transforming the company formerly traded as CYCN into a publicly traded, preclinical-stage
GlucoTrack (NASDAQ: GCTK) has outlined plans to pursue U.S. regulatory clearance for its glucose monitoring device, a development that quickly
iTonic Holdings (NASDAQ: ITOC) announced a $20 million private placement deal on Monday, sparking a sharp rally in after-hours trading—even
Scienture Holdings (NASDAQ: SCNX) has secured several group purchasing organization (GPO) agreements that significantly expand institutional access to its overdose
7 months ago
